University of Barcelona
Clinical Trials
80
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (68 trials with phase data)• Click on a phase to view related trials
Reframing Expectations About Aging - Physical Activity and Inclusive Reappraisal
- Conditions
- Self-perceptions of AgingPhysical Activity
- First Posted Date
- 2025-08-11
- Last Posted Date
- 2025-08-19
- Lead Sponsor
- University of Barcelona
- Target Recruit Count
- 342
- Registration Number
- NCT07113860
- Locations
- 🇪🇸
Department of Clinical Psychology and Psychobiology at the University of Barcelona., Barcelona, Catalonia, Spain
Nursing Interventions in Communication for the Critically Ill Patient: CONECTEM Programme
- Conditions
- Critical IllnessNurse-patient Communication
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- University of Barcelona
- Target Recruit Count
- 180
- Registration Number
- NCT06901882
- Locations
- 🇪🇸
University of Barcelona, Hospitalet de Llobregat, Catalonia, Spain
Monolithic Zirconia Posterior Single Crowns: a Randomized Clinical Trial.
- Conditions
- Posterior Single Edentulous Sites
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- University of Barcelona
- Target Recruit Count
- 50
- Registration Number
- NCT06865209
- Locations
- 🇪🇸
Hospital Odontolico de Bellvitge Universidad de Barcelona, Barcelona, Spain
Pharmaceutical Literacy and Quality of Life in Spanish Population.
- Conditions
- Health Related Quality of LifeLiteracy
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- University of Barcelona
- Target Recruit Count
- 1246
- Registration Number
- NCT06729697
- Locations
- 🇪🇸
Clinical Pharmacy and Pharmaceutical Care Unit., Barcelona, Spain
Effectiveness of a Multidisciplinary Treatment for Patients with Chronic Low Back Pain
- Conditions
- Chronic Low-back Pain (cLBP)Chronic Low-back PainBack Pain
- Interventions
- Drug: Usual CareBehavioral: Multidisciplinary and multimodal intervention
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- University of Barcelona
- Target Recruit Count
- 62
- Registration Number
- NCT06679205
- Locations
- 🇪🇸
Hospital Clínic de Barcelona, Barcelona, Spain
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
News
EMA Designates Allopurinol as First Orphan Drug for Marfan Syndrome
The European Medicines Agency has designated allopurinol as the first orphan drug for Marfan syndrome, a rare connective tissue disease affecting approximately 7 in 100,000 people in the European Union.
Bladder-Preserving Treatment Shows Promise: Radiation Plus Dual Immunotherapy Achieves 93% Complete Response in MIBC
A novel combination of radiation therapy with durvalumab and tremelimumab immunotherapy achieved a 93% complete response rate in muscle-invasive bladder cancer patients, offering a promising bladder-preserving alternative.